Duangchai Narawong
Neurology · Des Moines, IANPI 1750376034
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 222 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations.
Across 222 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$723
- Supernus Pharmaceuticals, Inc.$643
- Neurelis, Inc.$393
- Jazz Pharmaceuticals Inc.$303
- Livanova USA, Inc.$280
- SK Life Science, Inc.$266
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,990100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 52 | $723 |
| Supernus Pharmaceuticals, Inc. | 61 | $643 |
| Neurelis, Inc. | 17 | $393 |
| Jazz Pharmaceuticals Inc. | 15 | $303 |
| Livanova USA, Inc. | 13 | $280 |
| SK Life Science, Inc. | 4 | $266 |
| Immedica Pharma US, Inc. | 7 | $173 |
| AstraZeneca | 7 | $162 |
| Biogen | 7 | $145 |
| Mallinckrodt Enterprises LLC | 2 | $137 |
| Catalyst Pharmaceuticals, Inc. | 6 | $121 |
| Greenwich Biosciences, Inc. | 3 | $120 |
| Intrabio Inc | 2 | $69 |
| Sunovion Pharmaceuticals Inc. | 8 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
| Zogenix Inc. | 2 | $59 |
| Acadia Pharmaceuticals Inc | 3 | $53 |
| Aquestive Therapeutics, Inc. | 2 | $52 |
| Amneal Pharmaceuticals LLC | 2 | $44 |
| Azurity Pharmaceuticals, Inc. | 2 | $38 |
| Pyros Pharmaceuticals, Inc. | 1 | $23 |
| Aucta Pharmaceuticals, Inc. | 1 | $22 |
| Baxter Healthcare | 1 | $18 |
| Biomarin Pharmaceutical Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,990 in reported general payments places this provider in the 80th percentile of 132 neurology providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrileptalOxcarbazepine | 12 | $17,296 |
| KeppraLevetiracetam | 12 | $6,898 |
| Topiramate ErTopiramate | 14 | $6,516 |
| Phenobarbital | 40 | $1,761 |
| Valproic AcidValproic Acid (As Sodium Salt) | 23 | $708 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $670 |
| Topiramate | 36 | $650 |
| Lamotrigine | 14 | $636 |
| Guanfacine Hcl | 12 | $587 |
| Divalproex Sodium | 11 | $189 |
| Baclofen | 16 | $79 |
Paid to pharmacies, not to this prescriber.
Other neurology in Des Moines
- Bruce HughesDes Moines$1.8M
- Michael JacobyDes Moines$243K
- Lynn RankinDes Moines$181K
- Wendy ZadehDes Moines$134K
- Paul BabikianDes Moines$107K
- Mark PuricelliDes Moines$45K
- Keith KohoutDes Moines$36K
- Erik ArnesonDes Moines$10K
- John WrightDes Moines$9K
- Lynn StruckDes Moines$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.